Jane Street’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.23K Sell
720
-2,167
-75% -$45.8K ﹤0.01% 11348
2025
Q4
$80.2K Buy
+2,887
New +$129K ﹤0.01% 10304
2023
Q3
Sell
-201
Closed -$147K 9023
2023
Q2
$147K Sell
201
-46
-19% -$35.7K ﹤0.01% 7823
2023
Q1
$186K Sell
247
-272
-52% -$237K ﹤0.01% 7895
2022
Q4
$990K Buy
+519
New +$205K ﹤0.01% 5004
2022
Q3
Sell
-27
Closed -$20K 10079
2022
Q2
$20K Sell
27
-21
-44% -$32.9K ﹤0.01% 9159
2022
Q1
$166K Buy
48
+41
+586% +$107K ﹤0.01% 9157
2021
Q4
$22K Buy
+7
New +$32.5K ﹤0.01% 9771
2021
Q3
Sell
-7
Closed -$60.4K 10339
2021
Q2
$88K Sell
7
-15
-68% -$236K ﹤0.01% 9318
2021
Q1
$363K Buy
+22
New +$429K ﹤0.01% 7385
2020
Q4
Sell
-14
Closed -$263K 7805
2020
Q3
$271K Buy
14
+9
+180% +$207K ﹤0.01% 6035
2020
Q2
$130K Buy
+5
New +$142K ﹤0.01% 6603

Other funds holding KALA

Jane Street's KALA Position: Q1 2026 in Review

Jane Street reduced its KALA BIO (KALA) stake by 75% in Q1 2026, selling an estimated $45.8K and leaving 720 shares worth $6.23K. The position accounts for ﹤0.01% of the portfolio, ranked #11348.

Jane Street first reported a position in KALA in Q2 2020 and has held it in 12 quarters since. The position peaked at $990K in Q4 2022. 28 funds tracked by Wall St. Rank hold KALA as of Q1 2026.

  • Jane Street held 720 shares of KALA BIO worth $6.23K as of Q1 2026.
  • Jane Street sold 2,167 KALA BIO shares in Q1 2026, an estimated $45.8K.
  • KALA BIO made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11348 holding.
  • Jane Street first reported a position in KALA BIO in Q2 2020 and has held it in 12 quarters since.
  • Jane Street's KALA BIO position peaked at $990K in Q4 2022.
  • 28 funds tracked by Wall St. Rank held KALA BIO as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.